papercuts
Bluelighter
- Joined
- Feb 10, 2021
- Messages
- 1,277
Here's the study
link.springer.com
The case study half way down, under fig1 sounds like my predicament.
I'm going to start a thread on it, see if anyone else knows anything.

Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy - European Archives of Psychiatry and Clinical Neuroscience
Buprenorphine is a partial μ-opioid agonist widely used for opioid maintenance therapy (OMT). It is mainly metabolized to pharmacologically active norbuprenorphine by the cytochrome P450 (CYP) isozyme 3A4. This may give rise to drug–drug interactions under combinations with inhibitors or...

I'm going to start a thread on it, see if anyone else knows anything.